Tag: ‘
Samsung Bioepis flags shifting PBM models and deepening price erosion in...
Q1 2026 Biosimilar Market Report tracks approvals, launches, pricing trends, and the potential impact of evolving PBM rebate frameworks on biosimilar uptake